
SCYNEXIS, Inc.
NASDAQ:SCYX
0.8583 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3.746 | 140.141 | 5.091 | 13.163 | 0 | 0.121 | 0.257 | 0.257 | 0.257 | 0.257 | 1.256 | 16.857 | 16.837 |
Cost of Revenue
| 0 | 15.624 | 0.628 | 0.312 | 0.303 | 0 | 0 | 0 | 0 | 0 | 15.446 | 16.305 | 14.364 |
Gross Profit
| 3.746 | 124.517 | 4.463 | 12.851 | -0.303 | 0.121 | 0.257 | 0.257 | 0.257 | 0.257 | -14.19 | 0.552 | 2.473 |
Gross Profit Ratio
| 1 | 0.889 | 0.877 | 0.976 | 0 | 1 | 1 | 1 | 1 | 1 | -11.298 | 0.033 | 0.147 |
Reseach & Development Expenses
| 26.405 | 30.928 | 27.259 | 23.773 | 36.522 | 38.394 | 21.56 | 18.326 | 20.076 | 16.44 | 8.287 | 4.363 | 8.927 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 8.68 | 8.251 | 7.998 | 12.166 | 7.568 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.048 | 0 | 0 |
SG&A
| 14.458 | 20.92 | 62.961 | 49.916 | 14.627 | 10.648 | 8.68 | 8.251 | 7.998 | 12.166 | 7.616 | 4.381 | 4.742 |
Other Expenses
| 0 | 0 | 0.003 | -0.013 | -0.334 | 0.538 | 0 | 0 | 0 | 0 | -0.01 | 4.381 | 0.012 |
Operating Expenses
| 40.863 | 51.848 | 90.22 | 73.676 | 50.815 | 49.042 | 30.24 | 26.577 | 28.074 | 28.606 | 15.903 | 8.744 | 13.669 |
Operating Income
| -37.117 | 72.669 | -85.757 | -60.825 | -51.149 | -48.921 | -29.983 | -26.32 | -27.817 | -28.349 | -14.647 | -7.204 | -7.784 |
Operating Income Ratio
| -9.908 | 0.519 | -16.845 | -4.621 | 0 | -404.306 | -116.665 | -102.412 | -108.237 | -110.307 | -11.662 | -0.427 | -0.462 |
Total Other Income Expenses Net
| 15.98 | -5.49 | 18.248 | 24.884 | -7.184 | -4.789 | 10.779 | 1.26 | -2.172 | 0.011 | 7.878 | -23.257 | -0.281 |
Income Before Tax
| -21.137 | 67.179 | -67.509 | -35.954 | -58.333 | -53.71 | -19.204 | -25.06 | -29.989 | -28.338 | -6.769 | -30.461 | -11.477 |
Income Before Tax Ratio
| -5.643 | 0.479 | -13.26 | -2.731 | 0 | -443.884 | -74.724 | -97.51 | -116.689 | -110.265 | -5.389 | -1.807 | -0.682 |
Income Tax Expense
| 0.151 | 0.138 | -4.7 | -3.088 | -3.148 | 1.524 | -6.736 | 1.855 | 0.351 | -4.285 | -1.166 | 11.886 | 0.984 |
Net Income
| -21.288 | 67.041 | -62.809 | -32.866 | -55.185 | -55.234 | -12.468 | -25.06 | -29.989 | -32.623 | -4.234 | -30.461 | -11.477 |
Net Income Ratio
| -5.683 | 0.478 | -12.337 | -2.497 | 0 | -456.479 | -48.514 | -97.51 | -116.689 | -126.938 | -3.371 | -1.807 | -0.682 |
EPS
| -0.44 | 1.4 | -1.47 | -1.25 | -5.15 | -9.85 | -2.84 | -9.37 | -15.75 | -26.82 | -7.48 | -192.64 | -72.58 |
EPS Diluted
| -0.44 | 1.39 | -1.47 | -1.25 | -5.15 | -9.85 | -2.84 | -9.37 | -15.75 | -26.82 | -7.13 | -192.64 | -72.58 |
EBITDA
| -20.309 | 73.479 | -59.909 | -31.414 | -51.149 | -51.268 | -17.097 | -23.164 | -29.512 | -27.902 | -2.193 | -13.761 | -9.707 |
EBITDA Ratio
| -5.422 | 0.524 | -16.759 | -4.689 | 0 | -401.967 | -112.696 | -100.751 | -107.805 | -108.568 | -11.285 | -0.614 | -0.749 |